Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pseudomyxoma Peritonei × Sirolimus × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 38 Leukemia, Myeloid, Acute 32 Myelodysplastic Syndromes 30 Multiple Myeloma 28 Lymphoma, Non-Hodgkin 27 Hodgkin Disease 27 Leukemia, Lymphocytic, Chronic, B-Cell 24 Graft vs Host Disease 24 Lymphoma 23 Leukemia 23 Hematologic Neoplasms 20 Lymphoma, Mantle-Cell 17 Sarcoma 16 Neoplasms 16 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 16 Tuberous Sclerosis 14 Myeloproliferative Disorders 14 Lymphoma, Large B-Cell, Diffuse 14 Burkitt Lymphoma 14 Breast Neoplasms 14 Recurrence 12 Lymphoma, Follicular 12 Waldenstrom Macroglobulinemia 11 Primary Myelofibrosis 11 Neoplasm Metastasis 11 Lymphoma, B-Cell, Marginal Zone 11 Leukemia, Myelomonocytic, Chronic 11 Neoplasms, Plasma Cell 10 Melanoma 10 Lymphangioleiomyomatosis 10

Interventions

Mitomycin 3 Hyperthermic Intraperitoneal Chemotherapy 3 Oxaliplatin 2 Leucovorin 2 Fluorouracil 2 Capecitabine 2 tislelizumab 1 molgramostim 1 irinotecan sucrosofate 1 cryoprecipitate coagulum 1 Tacrolimus 1 Surveys and Questionnaires 1 Specimen Handling 1 Sirolimus 1 Radiosurgery 1 Psychiatric Rehabilitation 1 Pharmacogenomic Testing 1 Observation 1 Nivolumab 1 Methods 1 Magnetic Resonance Spectroscopy 1 Lansoprazole 1 Ipilimumab 1 Ifosfamide 1 Gemcitabine 1 Floxuridine 1 Early Intervention, Educational 1 Doxorubicin 1 Cytoreduction Surgical Procedures 1 Clarithromycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06084780 2026-01-23

TRANSCAPE

Case Comprehensive Cancer Center

Phase 2 Not yet recruiting

Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon ⚡